Hackensack, New Jersey (August 14, 2024)—MAX Surgical Specialty Management proudly welcomes Brian Lawson as the new Senior Vice President of Business Development. With a 15-year legacy of success in strategy, growth, and M&A across the healthcare industry, Brian’s arrival marks a significant milestone for MAX as it redefines and elevates the delivery of services and support to leading oral and maxillofacial surgical practices.
“MAX’s growth and evolution have always been driven by the talent, enthusiasm, and experience of the people we bring on board,” says Dr. Auerbach. “Brian brings with him a proven track record in business development. I’m excited to collaborate with him and the rest of the MAX team as we continue to build an outstanding company that redefines the role of specialty healthcare management.”
Before joining MAX, Brian served as Chief Development Officer at SALT Dental Collective, where he spearheaded the firm’s explosive growth from 18 locations in two states to an impressive 100 locations in ten states. His leadership in business development at Covenant Physician Partners and SAGE Veterinary Centers, coupled with his investment banking expertise at Harris Williams & Co., further cements his reputation as a transformative leader.
Dr. Auerbach and Co-CEO Mark Censoprano share a unified vision for the future of MAX, and Brian is the newest addition to help advance that mission. “Brian’s experience and expertise are a tremendous value to our team,” said Mark Censoprano. “I look forward to working closely with him to further strengthen MAX’s growth and enhance our support to our surgeons.”
Brian’s dedication to MAX’s mission—centered on providing top-tier support and services to advance oral and maxillofacial care—perfectly aligns with the organization’s goals. With his leadership, the future of MAX’s business development is poised for significant success.
###
MEDIA CONTACTS:
Sabrina Levine Communications
Sabrina Levine | sabrina@sabrinalevinepr.com | (917) 769-4434
Nicole Waldman | nicole@sabrinalevinepr.com | (805) 404-8152
About Brian Lawson:
Brian Lawson brings over 15 years of experience in strategy, growth, and M&A in the healthcare services sector, with a proven track record of success in developing and executing growth strategies for private equity-backed healthcare services companies. Prior to joining MAX, Brian served as Chief Development Officer at SALT Dental Collective, where he led the firm’s efforts to identify, source, and execute new practice partnerships, driving growth from 18 locations in two states to 100 locations in ten states during his tenure with the company. Brian has also served in various leadership roles in business development at Covenant Physician Partners and SAGE Veterinary Centers, as well as in investment banking at Harris Williams & Co. Brian holds an M.B.A. from Vanderbilt University and a B.S. from Northwest Missouri State University. He is based in Brentwood, TN, where he resides with his wife and two children. https://www.linkedin.com/in/bdlawson04/overlay/contact-info/
About Dr. Jason Auerbach:
Dr. Jason M. Auerbach is a renowned Oral and Maxillofacial Surgeon certified by both the American Board of Oral and Maxillofacial Surgery and the National Dental Board of Anesthesiology. This dual certification – and the expertise it reflects – enables Dr. Auerbach to provide patients with the full range of oral and maxillofacial surgery services, including laser-assisted dental implant surgery, advanced bone grafting, wisdom tooth extraction, exposures of impacted canines for orthodontic patients, and more. He is also known internationally as an industry leader through his handle @bloodytoothguy (190K) on social media, where he educates rising dental stars. Dr. Auerbach founded Riverside Oral Surgery in 2007 and, in doing so, began to realize his vision of providing the optimal patient experience through clinical excellence, compassionate care, and close attention to every detail. This is now the leading full-scope oral group in New Jersey, with 9 locations and 15 surgeons. It is the official practice for the New Jersey Devils. Dr. Auerbach’s newest venture is MAX Surgical Specialty Management LLC, the leading disruptor in surgeon-led OMS platforms. MAX is changing the landscape for what was known possible to private practice owners, supporting 28 surgeons in 4 states across the Northeast.
About Mark Censoprano:
Mark Censoprano is a seasoned executive with over three decades of experience in competitive industries, including leadership roles at prestigious organizations and successful healthcare startups. Mark’s career began after completing a selective joint BS/MBA degree program at Cornell University. He then spent a significant period at S.C. Johnson & Son, a FORTUNE Top 100 Best Companies to Work For, where he honed his business discipline and achieved growth for top brands in brand management roles. Following his tenure at S.C. Johnson & Son, Mark led businesses and launched new products at Campbell Soup Company’s Soup division, achieving several record-breaking product launches. As Senior Vice President at Darden Restaurants’ $3.3B Olive Garden concept, another FORTUNE Top 100 Best Companies to Work For, Mark delivered record-setting business results, outperforming all other brands in the casual dining category. In 2012, Mark became Chief Marketing Officer at Aspen Dental, leading various functions and spearheading a successful brand relaunch, resulting in historic sales, profits, patient counts, and employee engagement scores. After holding c-suite roles in the retail industry, Mark joined Guardian Dentistry Partners, a startup, where he played a pivotal role in growing the company, earning recognition as a top company to work for and partner with within the industry. Mark’s innovative efforts have been recognized by industry publications such as Ad Age, Brandweek, and USA Today. He has also received an Effie Award for Sustained Business Success.
About MAX Surgical Specialty Management:
Based in Hackensack, New Jersey, MAX Surgical Specialty Management is a management services organization that partners with premier oral and maxillofacial surgery (OMS) practices to drive and support clinical excellence and a superior patient experience with the intention of creating the ultimate surgeon-led OMS platform. Backed by MedEquity Capital, RF Investment Partners, and Kian Capital, MAX is committed to building the region’s first OMS-only specialty platform where surgeons’ autonomy, independent practice identity, and clinical excellence are organizational imperatives. MAX provides a superior platform to support strategic practice growth as well as scalable, effective, and efficient daily operations required to meet the needs of top-performing OMS practices. Further information is available at www.max-ssm.com.
About MedEquity Capital:
Headquartered in Wellesley, Massachusetts, MedEquity Capital is a healthcare private equity firm that focuses on investing in profitable healthcare services business, most often in the lower middle-market. Since its founding over 20 years ago, MedEquity has invested over $400 million of equity capital, with top decile returns for its investors. Further information is available at www.medequity.com.
About RF Investment Partners:
RF Investment Partners provides capital ranging in size from $5 million to $30 million to support leading domestic, lower-middle-market companies. RF partners with family-owned and private businesses in a variety of situations, including acquisition financing, growth capital investments, recapitalizations, refinancings, and management buyouts. RF’s investment professionals have considerable experience investing across the capital structure and have the flexibility to structure deals to meet the distinct needs of each company and situation. RF invests in unitranche, second lien, and subordinated debt, alongside preferred and common equity. Further information is available at www.rf-partners.com.